Aquatic Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,066
| Closed | -$1.7M | – | 1284 |
|
|
2025
Q1 | $1.7M | Buy |
70,066
+40,805
| +139% | +$990K | 0.04% | 455 |
|
|
2024
Q4 | $611K | Sell |
29,261
-18,008
| -38% | -$376K | 0.02% | 673 |
|
|
2024
Q3 | $940K | Buy |
47,269
+32,569
| +222% | +$647K | 0.02% | 513 |
|
|
2024
Q2 | $228K | Buy |
14,700
+5,200
| +55% | +$80.5K | 0.01% | 722 |
|
|
2024
Q1 | $151K | Buy |
+9,500
| New | +$151K | ﹤0.01% | 830 |
|
|
2023
Q4 | – | Sell |
-31,700
| Closed | -$371K | – | 1375 |
|
|
2023
Q3 | $371K | Buy |
+31,700
| New | +$371K | 0.02% | 544 |
|
|
2023
Q2 | – | Sell |
-103,400
| Closed | -$1.71M | – | 1408 |
|
|
2023
Q1 | $1.71M | Buy |
+103,400
| New | +$1.71M | 0.11% | 211 |
|
|
2022
Q4 | – | Sell |
-300
| Closed | -$4K | – | 1443 |
|
|
2022
Q3 | $4K | Sell |
300
-7,500
| -96% | -$100K | ﹤0.01% | 1096 |
|
|
2022
Q2 | $55K | Buy |
+7,800
| New | +$55K | 0.02% | 623 |
|